Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: May 16, 2024
Date Accepted: Feb 12, 2025
Date Submitted to PubMed: Feb 12, 2025

The final, peer-reviewed published version of this preprint can be found here:

Patient and Provider Perspectives of a Web-Based Intervention to Support Symptom Management After Radioactive Iodine Treatment for Differentiated Thyroid Cancer: Qualitative Study

Carr AL, Jenkins AM, Jonklaas J, Gabriel K, Miller K, Graves K

Patient and Provider Perspectives of a Web-Based Intervention to Support Symptom Management After Radioactive Iodine Treatment for Differentiated Thyroid Cancer: Qualitative Study

JMIR Form Res 2025;9:e60588

DOI: 10.2196/60588

PMID: 39937181

PMCID: 11939019

Patient and Provider Perspectives of a Web-based Intervention to Support Symptom Management after Radioactive Iodine Treatment for Differentiated Thyroid Cancer: Qualitative Study

  • Alaina L Carr; 
  • Angela Marie Jenkins; 
  • Jacqueline Jonklaas; 
  • Kate Gabriel; 
  • Kristen Miller; 
  • Kristi Graves

ABSTRACT

Background:

Patients diagnosed with differentiated thyroid cancer (DTC) who receive radioactive iodine (RAI) treatment experience acute, medium, and late treatment effects. While the timing of these effects varies by individual, common post-treatment effects include dry mouth, salivary gland swelling, dry eyes, dental caries, and nose bleeds. The nature of symptoms due to RAI treatment can impact patient health-related quality of life (HRQOL). Adequate information during the post-primary treatment phase remains an unmet need among this population.

Objective:

This qualitative study aimed to identify and understand potential self-management strategies for RAI-specific symptom burden from the perspectives of patients and stakeholders (cancer care providers and patient advocates).‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬ An additional aim included assessing the features and functionalities desirable in the formative work for a web-based intervention to effectively engage patients in their self-management and survivorship care.

Methods:

We conducted six focus groups with 22 patients diagnosed with DTC who completed RAI treatment and 12 individual stakeholder interviews with providers involved in DTC care. We elicited participants’ perspectives on a symptom management web-based intervention. Prior to the interviews, participants completed a demographics survey. A moderator used semi-structured interview guides during patient focus groups and stakeholder interviews to obtain feedback on the content and layout of the intervention. Interviews were audio recorded, deidentified, and transcribed. Content analysis was performed on focus group and stakeholder interviews.

Results:

Participants identified the most prevalent RAI symptoms that were difficult to manage as: dry mouth, salivary gland swelling, and changes in taste. Across focus groups and stakeholder interviews, nutrition-based symptom management strategies, communication with family members, and practical survivorship follow-up information emerged as additional helpful content to include in the web-based supportive care intervention. Feedback elicited from both groups found education and symptom management videos to be helpful in patient self-management of RAI symptoms, whereas patients and stakeholders provided mixed feedback on the benefits of the frequently asked questions page.

Conclusions:

Results from focus group participants and stakeholders in the intervention planning process of this study suggest key intervention components to empower patients with DTC to self-manage RAI symptoms on a web-based platform.


 Citation

Please cite as:

Carr AL, Jenkins AM, Jonklaas J, Gabriel K, Miller K, Graves K

Patient and Provider Perspectives of a Web-Based Intervention to Support Symptom Management After Radioactive Iodine Treatment for Differentiated Thyroid Cancer: Qualitative Study

JMIR Form Res 2025;9:e60588

DOI: 10.2196/60588

PMID: 39937181

PMCID: 11939019

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.